Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Change in Acquisitions & Divestments (2016 - 2025)

Perspective Therapeutics' Change in Acquisitions & Divestments history spans 9 years, with the latest figure at -$21.7 million for Q2 2025.

  • For Q2 2025, Change in Acquisitions & Divestments changed N/A year-over-year to -$21.7 million; the TTM value through Sep 2025 reached $40.5 million, up 5.96%, while the annual FY2024 figure was $78.7 million, 245.85% up from the prior year.
  • Change in Acquisitions & Divestments for Q2 2025 was -$21.7 million at Perspective Therapeutics, down from $21.7 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $40.5 million in Q4 2024 and bottomed at -$21.7 million in Q2 2025.
  • The 4-year median for Change in Acquisitions & Divestments is $21.7 million (2025), against an average of $14.5 million.